BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Marketing

Servier's Tibsovo® approved by European Commission for IDH1-mutated AML and Cholangiocarcinoma

Marketing Authorization granted for Tibsovo® as the first and only approved IDH1 targeted therapy in Europe IDH1-mutate...

May 11, 2023 | Regulatory

PerkinElmer Unveils Revvity, its Innovative Science-Based Solutions Company for Life Sciences and Diagnostics

Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...

May 09, 2023 | News

Hasten Biopharma Acquires Chinese Commercial Rights for Roche's Rocephin® Antibiotic.

Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a long-...

May 05, 2023 | News

Asieris subsidiary obtains "Drug Distribution License" for commercialization strategy.

Hainan Asieris' acquisition of the Drug Distribution Licence is a critical step towards improvement in the quality of drug circulation services, standardiz...

April 11, 2023 | News

Pharma marketing future and present: AI & Modular Content in APAC focus

At the same time, it is crucial to understand that the implementation of AI and ML technologies requires eradicative change within the whole company struct...

March 31, 2023 | News

Indian Immunologicals Limited receives regulatory approval for Measles-Rubella (MR) Vaccine

Indian Immunologicals Limited (IIL), a leading vaccine manufacturer has announced receipt of approval from Drugs Controller General of India and State...

March 28, 2023 | News

Mallinckrodt's CELLEX® ECP System Reimbursed in Japan for cGvHD Treatment

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD &nd...

March 09, 2023 | News

Abacus Medicine Pharma Services and AddMedica Sign Partnership Agreement for the Distribution of Siklos® in Benelux

Simon Estcourt, Managing Director of Abacus Medicine Pharma Services explains: “This partnership agreement between Abacus Medicine Pharma Servic...

March 07, 2023 | News

Lexicon Reveals “INTO THE DARK” Awareness Campaign

Emphasizes challenges faced by patients and clinicians within the first 30 days after discharge from a heart failure hospitalization Reinforces im...

March 06, 2023 | News

Biogen Japan and Eisai Provide Update on Co-Promotion Of Multiple Sclerosis Treatments In Japan

The two companies have been jointly engaged in promotional activities for MS treatments in Japan. However, since a certain objective has been achieved rega...

March 02, 2023 | News

Karyopharm and Menarini Group Receive Full Marketing Authorization

Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication – - Karyopharm Therapeutics Inc. (Nasda...

February 22, 2023 | News

Dolomite Bio announces re brand to Do Bio

The expertise behind Do bio’s technology is built on a strong foundation in the field of microfluidics. As the company has grown in recent years, the...

February 09, 2023 | News

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences...

February 09, 2023 | News

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings Biosynex SA (“Biosynex”) (EPA: ALBIO), a French m...

February 01, 2023 | News

Stay Connected